“Efficacy and Safety of Oral Nalbuphine Extended Release in Prurigo Nodularis: Results of a Phase 2, Randomized, Controlled Trial With an Open Open-Label Extension Phase”. SKIN The Journal of Cutaneous Medicine 5, no. 1 (January 1, 2021): s29. Accessed April 19, 2025. https://skin.dermsquared.com/skin/article/view/1180.